Lamesa, Saldy T.

HRN: 28-65-37  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/03/2026
03/09/2026
IV
4.5gm
Q8
DM Foot Right
Checking Initial Appropriateness 

 Indication:  Empirical Escalation    Type of Infection:  BloodstreamSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines